---
title: 'Tackling ALT-positive neuroblastoma: is it time to redefine risk classification
  systems? A systematic review with IPD meta-analysis'
date: '2024-12-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39733691/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241230170904&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our study highlights poorer outcomes in ALT-positive neuroblastoma
  patients, emphasizing the need to integrate TMM status into international risk classification
  guidelines. Standardizing TMM assessment is key for refining treatment strategies,
  considering the unique biology of ALT-positive ...'
disable_comments: true
---
CONCLUSIONS: Our study highlights poorer outcomes in ALT-positive neuroblastoma patients, emphasizing the need to integrate TMM status into international risk classification guidelines. Standardizing TMM assessment is key for refining treatment strategies, considering the unique biology of ALT-positive ...